Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ketamine Media is a healthcare-focused marketing and practice growth company serving ketamine, psychedelic-wellness, and broader behavioral health providers. Founded in 2016, the company offers branding, inbound marketing, SEO, PPC, content strategy, website development, and marketing automation designed to help clinics raise awareness and attract patients. Its business is centered on supporting providers offering ketamine infusion therapy, ketamine-assisted psychotherapy, Spravato, TMS, and related mental health services rather than developing therapeutics. Ketamine Media was acquired by Irwin Naturals in March 2023 but continues to operate under the Ketamine Media brand. The company positions itself as the industry's first dedicated ketamine marketing agency and a growth platform for clinics offering ketamine-assisted therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ketamine Media.